1-7 of 7
John C. Reed, M.D., Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Triptolide Sensitizes Leukemic Cells to TRAIL Induced Apoptosis Via Decrease of XIAP and p53-Mediated Increase of DR5.

Bing Z. Carter, PhD, Duncan H. Mak, Wendy D. Schober, Martin Dietrich, Clemencia Pinilla, Ph.D., John C. Reed, M.D., Ph.D., Michael Andreeff, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 528.
https://doi.org/10.1182/blood.V108.11.528.528
Published: 2006
Journal Articles

A Novel Peptide Containing a Nine Amino Acid Sequence from Nur77 Induces Bcl-2-Dependent Apoptosis in AML.

Michael Andreeff, MD, PhD, Marina Konopleva, M.D., Ph.D., Julie C. Watt, Ismael J. Samudio, Ph.D., Arnold C. Satterthwait, Ph.D., Shinichi Kitada, M.D., Ph.D., Xiao-kun Zhang, Ph.D., John C. Reed, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2607.
https://doi.org/10.1182/blood.V108.11.2607.2607
Published: 2006
Journal Articles

AML Progenitor/Stem Cells Overexpress XIAP and Are Sensitive to the Small Molecular XIAP Inhibitor 1396-11.

Bing Z. Carter, PhD, Tae Kon Kim, Duncan H. Mak, Wei Hu, Clemencia Pinilla, Ph.D., John C. Reed, M.D., Ph.D., Michael Andreeff, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2586.
https://doi.org/10.1182/blood.V108.11.2586.2586
Published: 2006
Journal Articles

Exploiting the Tr3 Interaction with Bcl-2 as a Novel Therapeutic Strategy of Cancer and Leukemia Therapy.

Dayong Zhai, PhD, Eduard Sergienko, Ph.D., Shinichi Kitada, M.D., Ph.D., Frederic Luciano, Ph.D., Arnold C. Satterswait, Ph.D., Xiaokun Zhang, B.S., John C. Reed, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 256.
https://doi.org/10.1182/blood.V108.11.256.256
Published: 2006
Journal Articles

Bcl-2 Antagonist ApoGossypol (NSC736630) Displays Single-Agent Activity in Bcl-2 Transgenic Mice and Has Superior Efficacy and Pharmacology with Less Toxicity Compared to Gossypol (NSC19048).

Shinichi Kitada, MD, PhD, Lee Jia, Ph.D., Lori C. Coward, Ph.D., Greg S. Gorman, Ph.D., Patricia Noker, Ph.D., Maurizio Pellecchia, Ph.D., John C. Reed, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2487.
https://doi.org/10.1182/blood.V108.11.2487.2487
Published: 2006
Journal Articles

Tcl-1 Inhibits Nuclear Export of TR3 and Is Highly Expressed in ZAP70-Positive CLL B-Cells.

Irene M. Pedersen, Ph.D., Frederic Luciano, Ph.D., Xiao-kun Zhang, Ph.D., Carlo M. Croce, Ph.D., Thomas J. Kipps, M.D., Ph.D., Dennis A. Carson, M.D., Ph.D., John C. Reed, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 967.
https://doi.org/10.1182/blood.V104.11.967.967
Published: 2004
Journal Articles

Pro-Apoptotic Effects on CLL (Chronic Lymphocytic Leukemia) of ABT-737, a Novel Fully Synthetic Bcl-2/Bcl-XL Antagonist.

Shinichi Kitada, M.D., Ph.D., Edward Monosov, Ph.D., Sharon Chandler, Ph.D., Esther D. Avery, B.S., Thomas J. Kipps, M.D., Ph.D., Saul H. Rosenberg, Ph.D., John C. Reed, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 952.
https://doi.org/10.1182/blood.V104.11.952.952
Published: 2004